SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
Spyre Therapeutics, Inc.
@SYRE_InsiderForm 4 Filing: Kiselak Tomas Sells $399.7M of $SYRE
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Spyre Therapeutics, Inc.
Ticker: $SYRE
Transaction Value
$399.7M
Price/Share: $74.68
transaction date
2026-06-23
Shares: 5,351,461
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kiselak Tomas, holds the title of Director at Spyre Therapeutics, Inc..
On 2026-06-23, the insider transacted 5,351,461 shares.The shares were transacted at a weighted average price of $74.68 per share, resulting in a total market-relevant value of $399.7M.
Executive Summary Summary
Kiselak Tomas (Director) sold $399.7M of $SYRE
Post-Transaction Position: 0 shares
SEC Accession No: 0001104659-26-076967 (CIK: 1830177)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.